Parasvil brings venture capital and private equity experience from Radical Ventures and KKR, alongside earlier consulting background at The Boston Consulting Group.
The London-based industrial technology company secured funding from Plural and NVentures to scale its non-toxic cooling fluids and modular data centre infrastructure.
"When people imagine a better future, they think about physical things: technologies that give them more freedom, more time, more life. AI will get us there faster. Frontier AI gives us PhD-level expertise across every discipline, meaning small, agile teams can move from materials discovery to commercial hardware in a way that simply wasn't possible before, so what used to take a decade, we can now do in months."
The financing round was co-led by Radical Ventures and Sofinnova Partners to accelerate the development of programmable biology tools.
"Every biotechnology or pharmaceutical company wants to be at the forefront of technology to find the best therapeutic molecules, yet not all are in a position to develop the most advanced AI models for the job. That’s where Latent Labs comes in. We push the frontiers of generative biology, giving our partners instant access to tools that accelerate their drug design programs."
The financing was co-led by Radical Ventures and Temasek to fuel expansion in the United States.
"The next generation of software won’t run on code, it will run on models fueled by training data. We let our clients easily turn human knowledge into AI models, improving the safety and accuracy of AI. This is incredibly powerful, and in the right hands, can literally save lives. If we want to build software that tackles unsolved frontiers in human health, or our climate, this is the only way"
